I-131 therapy for Graves' disease with giant goiter

被引：0
作者：
Jinguji, M. [1 ]
Nakajo, M. [1 ]
Tani, A. [1 ]
Yoshiura, T. [1 ]
机构：
[1] Kagoshima Univ, Dept Radiol, Grad Sch Med & Dent Sci, Kagoshima, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0595
引用
收藏
页码：S654 / S655
页数：2
相关论文
共 50 条
[31]   Accuracy of early I-131 uptake measurements in dose calculation for I-131 treatment of graves' disease. [J].
Dunkelmann, S ;
Schuemichen, C ;
Rudolph, F ;
Prillwitz, A ;
Groth, P .
JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) :131P-131P
[32]   VANDERBILT EXPERIENCE WITH I-131 TREATMENT FOR GRAVES-DISEASE [J].
DOUGLAS, JG .
SOUTHERN MEDICAL JOURNAL, 1973, 66 (01) :92-94
[33]   Zum Auftreten einer Immunhyperthyreose nach Radiojodtherapie von SchilddrüsenautonomienPrevalence of graves’ disease following treatment of autonomous goiter with I-131 therapy [J].
Christine Hirsch ;
Johann L. Spyra ;
Heinz R. Langhammer ;
Christian Laubenbacher ;
Reingard Senekowitsch-Schmidtke ;
Markus Schwaiger .
Medizinische Klinik, 1997, 92 (3) :130-137
[34]   OPTIMAL I-131 DOSE IN GRAVES-DISEASE - REPLY [J].
NORDYKE, RA ;
GILBERT, FI .
JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (12) :2360-2360
[35]   DIFFUSE TOXIC GOITER TREATED WITH I-131 [J].
GUZMAN, JR ;
TREVINO, OG ;
VAZQUEZ, CL ;
MAISTERRENA, J .
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1987, 39 (01) :11-18
[36]   ENDEMIC GOITER IN VENEZUELA STUDIED WITH I-131 [J].
ROCHE, M ;
DEVENANZI, F ;
VERA, J ;
COLL, E ;
SPINETTIBERTI, M ;
MENDEZMARTINEZ, J ;
GERARDI, A ;
FORERO, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1957, 17 (01) :99-110
[37]   ANALYSIS OF CURATIVE EFFECT AND INFLUENCING FACTORS OF 131I TREATMENT OF PATIENTS WITH GRAVES' DISEASE AND GIANT GOITER [J].
Gao, Yun ;
Pan, Yi ;
Wang, Ting-Ting ;
Jia, Bing .
ACTA MEDICA MEDITERRANEA, 2020, 36 (02) :1095-1099
[38]   OUTCOME FOLLOWING STANDARDIZED 185 MBQ DOSE I-131 THERAPY FOR GRAVES-DISEASE [J].
WATSON, AB ;
BROWNLIE, BEW ;
FRAMPTON, CM ;
TURNER, JG ;
ROGERS, TGH .
CLINICAL ENDOCRINOLOGY, 1988, 28 (05) :487-496
[39]   The Outcome of I-131 Therapy for Graves Disease and Toxic Nodular, Multinodular Qoiter in Endemic Region [J].
Serdengecti, M. ;
Sari, O. ;
Ayan, A. ;
Dostbil, Z. ;
Ozturk, I. S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 :S202-S203
[40]   I-131 THERAPY FOR GRAVES-DISEASE - MULTIVARIATE-ANALYSIS OF PRETREATMENT PARAMETERS AND OUTCOME [J].
TURNER, JG ;
SADLER, WA ;
BROWNLIE, BEW ;
ROGERS, TGH .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (06) :679-679
12345